ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan
· Delayed Price · Currency is TWD 28.35
-0.20 (-0.70%)
May 13, 2025, 1:30 PM CST
ShareHope Medicine Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 3,716 | 3,795 | 4,147 | 4,057 | 3,087 | 3,788 | Upgrade
|
| Market Cap Growth | -8.49% | -8.49% | 2.20% | 31.44% | -18.51% | 23.63% | Upgrade
|
| Enterprise Value | 4,349 | 4,818 | 5,404 | 5,292 | 3,547 | 3,467 | Upgrade
|
| Last Close Price | 28.35 | 28.95 | 31.24 | 30.13 | 22.62 | 27.38 | Upgrade
|
| PE Ratio | 18.07 | 18.97 | 33.29 | 13.80 | 13.27 | 15.29 | Upgrade
|
| Forward PE | - | 20.25 | 20.25 | 20.25 | 20.25 | 20.25 | Upgrade
|
| PS Ratio | 0.84 | 0.88 | 1.07 | 0.98 | 0.80 | 0.92 | Upgrade
|
| PB Ratio | 0.94 | 0.95 | 1.05 | 0.99 | 0.80 | 1.06 | Upgrade
|
| P/TBV Ratio | 1.15 | 1.17 | 1.32 | 1.32 | 1.10 | 1.47 | Upgrade
|
| P/FCF Ratio | 34.58 | 20.67 | 607.42 | - | 13.87 | 10.53 | Upgrade
|
| P/OCF Ratio | 19.07 | 14.23 | 16.13 | 6.32 | 8.57 | 5.28 | Upgrade
|
| EV/Sales Ratio | 0.99 | 1.11 | 1.40 | 1.28 | 0.92 | 0.85 | Upgrade
|
| EV/EBITDA Ratio | 13.61 | 22.43 | 19.57 | 10.59 | 8.15 | 5.29 | Upgrade
|
| EV/EBIT Ratio | 84.30 | 113.07 | 57.07 | 16.07 | 13.95 | 6.75 | Upgrade
|
| EV/FCF Ratio | 40.47 | 26.24 | 791.50 | - | 15.94 | 9.63 | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.50 | 0.55 | 0.49 | 0.31 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 5.90 | 5.90 | 5.41 | 3.19 | 2.19 | 1.34 | Upgrade
|
| Debt / FCF Ratio | 10.82 | 10.82 | 319.32 | - | 5.43 | 2.69 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.52 | 0.61 | 0.65 | 0.83 | Upgrade
|
| Inventory Turnover | 12.27 | 12.27 | 11.06 | 11.20 | 9.69 | 10.17 | Upgrade
|
| Quick Ratio | 1.63 | 1.63 | 1.45 | 1.66 | 1.91 | 1.68 | Upgrade
|
| Current Ratio | 1.82 | 1.82 | 1.65 | 1.85 | 2.14 | 1.91 | Upgrade
|
| Return on Equity (ROE) | 3.08% | 3.08% | 1.37% | 6.12% | 5.18% | 11.50% | Upgrade
|
| Return on Assets (ROA) | 0.37% | 0.37% | 0.80% | 3.05% | 2.69% | 6.49% | Upgrade
|
| Return on Capital (ROIC) | 0.44% | 0.44% | 0.97% | 3.68% | 3.30% | 8.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.80% | 0.80% | 1.70% | 5.80% | 5.50% | 12.80% | Upgrade
|
| Earnings Yield | 5.56% | 5.27% | 3.00% | 7.25% | 7.54% | 6.54% | Upgrade
|
| FCF Yield | 2.89% | 4.84% | 0.17% | -15.37% | 7.21% | 9.50% | Upgrade
|
| Dividend Yield | 1.35% | - | 1.23% | 1.52% | 1.93% | 1.52% | Upgrade
|
| Payout Ratio | 24.40% | 25.20% | 48.19% | 19.45% | 44.19% | 0.85% | Upgrade
|
| Buyback Yield / Dilution | -0.05% | -0.05% | 0.26% | 0.28% | 1.83% | -0.03% | Upgrade
|
| Total Shareholder Return | 1.30% | -0.05% | 1.49% | 1.80% | 3.76% | 1.48% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.